TLR7 AGONISTS
The present invention relates to TLR7 agonists according to Formula (I) and their use in the treatment of diseases such as cancer and infectious disease. La presente invención se refiere a agonistas de TLR7 de acuerdo con la Formula I y su uso en el tratamiento de enfermedades tales como el cáncer y...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English Spanish |
| Published |
25.03.2021
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to TLR7 agonists according to Formula (I) and their use in the treatment of diseases such as cancer and infectious disease.
La presente invención se refiere a agonistas de TLR7 de acuerdo con la Formula I y su uso en el tratamiento de enfermedades tales como el cáncer y enfermedades infecciosas.(ver formula). |
|---|---|
| AbstractList | The present invention relates to TLR7 agonists according to Formula (I) and their use in the treatment of diseases such as cancer and infectious disease.
La presente invención se refiere a agonistas de TLR7 de acuerdo con la Formula I y su uso en el tratamiento de enfermedades tales como el cáncer y enfermedades infecciosas.(ver formula). |
| Author | WEBBER Stephen E APPLEMAN James Richard |
| Author_xml | – fullname: WEBBER Stephen E – fullname: APPLEMAN James Richard |
| BookMark | eNrjYmDJy89L5WTgDfEJMldwdPf38wwOCeZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfG-EUYGRgYGhkZmhmaOxkQpAgCgfx7V |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | AGONISTAS DEL RECEPTOR TIPO TOLL (TLR7). |
| ExternalDocumentID | MX2020012616A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_MX2020012616A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Oct 11 05:27:47 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Spanish |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_MX2020012616A3 |
| Notes | Application Number: MX20200012616 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210325&DB=EPODOC&CC=MX&NR=2020012616A |
| ParticipantIDs | epo_espacenet_MX2020012616A |
| PublicationCentury | 2000 |
| PublicationDate | 20210325 |
| PublicationDateYYYYMMDD | 2021-03-25 |
| PublicationDate_xml | – month: 03 year: 2021 text: 20210325 day: 25 |
| PublicationDecade | 2020 |
| PublicationYear | 2021 |
| RelatedCompanies | PRIMMUNE THERAPEUTICS, INC |
| RelatedCompanies_xml | – name: PRIMMUNE THERAPEUTICS, INC |
| Score | 3.172255 |
| Snippet | The present invention relates to TLR7 agonists according to Formula (I) and their use in the treatment of diseases such as cancer and infectious disease.
La... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | TLR7 AGONISTS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210325&DB=EPODOC&locale=&CC=MX&NR=2020012616A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQG2KVKAOUk30dggVdckzchU1yLZBEiYpVkaJ4OqdPBJTL5-Zh6hJl4RphFMDNmwvTDgc0LLwYcjAnNUMjC_l4DL6wLEIJYLeG1lsX5SJlAo394txNZFDdo7NgIdD2eq5uJk6xrg7-LvrObsbOsboeYXBJID1exmhmaOzAyswHa0OSg7uIY5gbalFCDXKW6CDGwBQOPySoQYmFKLhRk4nWFXrwkzcPhCZ7yBTGjmKxZh4A3xCTJXcHT39_MMDgkWZVBycw1x9tAFmhsP90W8bwSSG4zFGFiA3ftUCQYFY8O0lJS0NEtgO8bEBFR3JJuYpYJOfQfv-0xMkWSQxmOQFF5ZaQYuUKCA1kwZmcowsJQUlabKAivRkiQ5sOcBtphxDQ |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQG2KVKAOUk30dggVdckzchU1yLZBEiYpVkaJ4OqdPBJTL5-Zh6hJl4RphFMDNmwvTDgc0LLwYcjAnNUMjC_l4DL6wLEIJYLeG1lsX5SJlAo394txNZFDdo7NgIdD2eq5uJk6xrg7-LvrObsbOsboeYXBJID1exmhmaOzAyswDa2OSg7uIY5gbalFCDXKW6CDGwBQOPySoQYmFKLhRk4nWFXrwkzcPhCZ7yBTGjmKxZh4A3xCTJXcHT39_MMDgkWZVBycw1x9tAFmhsP90W8bwSSG4zFGFiA3ftUCQYFY8O0lJS0NEtgO8bEBFR3JJuYpYJOfQfv-0xMkWSQxmOQFF5ZeQZOjxBfn3gfTz9vaQYuUACB1k8ZmcowsJQUlabKAivUkiQ5cEAAAC4NdAA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TLR7+AGONISTS&rft.inventor=WEBBER+Stephen+E&rft.inventor=APPLEMAN+James+Richard&rft.date=2021-03-25&rft.externalDBID=A&rft.externalDocID=MX2020012616A |